Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent radiation and temozolomide followed by temozolomide + lomustine in pediatric high grade glioma
2006-005077-21Phase 2Completed
- Sponsor
- Dutch Childhood Oncology Group
- Start
- Oct 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide and lomustine in high-grade glioma (HGG), anaplastic astrocytoma (AA), glioblastoma (GBM) and 1 more, sponsored by Dutch Childhood Oncology Group. Primary endpoint: Event-free survival. Started Oct 2006; status: completed.
02
Drugs
temozolomidelomustine
03
Conditions
high-grade glioma (HGG)anaplastic astrocytoma (AA)glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on 2006-005077-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005077-21.